United Patients Group Applauds Anti-Overdose Initiatives of Cannabis Edibles Leader Auntie Dolores
San Francisco, CA (PRWEB) April 02, 2015
United Patients Group, the leading medical cannabis information and educational site, is proud to recognize Auntie Dolores for exhibiting leadership in initiatives that promote and enable responsible consumption of cannabis-infused edibles. New enhanced product labeling and lower dosages per unit aim to reduce incidents of over medicating.
Oakland California - based Auntie Dolores has stepped up efforts to create safety standards for the cannabis edibles industry in California. The early adopter of testing to ensure products do not contain unsafe levels of contaminants like heavy metals, pesticides, herbicides, and mold, is now focused on helping patients avoid consuming more than their recommended dose of cannabinoids and experiencing unpleasant feelings.
"While cannabinoids are neither toxic nor chemically dangerous, certain ones can alter perceptions when consumed in large doses," said Lauren Fraser, President of Auntie Dolores. "Our current goal is to help inexperienced consumers and low-THC-tolerant patients by offering less potent products and education."
Auntie Dolores's standard dosages and potency cap of 200 mg of delta-9-THC are reflected in the cannabis-infused edibles maker's enhanced packaging, which clearly quantifies the product's potency and conveys dosage information.
"Cannabis is a Godsend to many patients who do not respond or cannot tolerate the side-effects of pharmaceuticals, and a bad first experience can be devastating to their recovery," said United Patients Group founder John Malanca. "It's a pleasure to be able to depend on a professional organization like Auntie Dolores that takes patient care seriously."
Responding to patient needs is nothing new for the cannabis-infused edibles maker. Since 2008, Auntie Dolores has created specialty lines of cannabis edibles for patients who avoid processed sugar, gluten, and products produced from animals. The company's new line of vegan brownies, for instance, do not contain eggs or dairy products, and pass on the refined sugar and high fructose corn syrup.
For more information about this subject or cannabinoid therapy, go to http://www.UnitedPatientsGroup.com.
For more information about Auntie Dolores, go to http://www.AuntieDolores.com.
About United Patients Group:
United Patients Group is the leading medical cannabis information and educational site that is dedicated to providing the most professional and safe resource for Medical Cannabis information.
Physicians can now learn about Medical Cannabis through their online CME courses in Cannabinoid Therapeutics.
While most online medical cannabis sites cater to patients already familiar with medical cannabis, the UnitedPatientsGroup.com website is a comprehensive and easy-to-use information source for people of all ages and experience levels, from novice users to experienced industry professionals. The site's News, Resource, and Blog pages introduce new patients to the ins and outs of medical cannabis healthcare, while helping experienced providers stay abreast of the latest developments in THC and CBD therapies.
A complimentary five-star-rated United Patients Group medical cannabis app is available on the iTunes app store for iPhone 3GS, iPhone 4, iPhone 4S, iPhone 5, iPod touch (3rd generation), iPod touch (4th generation), and any iPad.
Read the full story at http://www.prweb.com/releases/Auntie-Dolores-Cannabis/Edibles/prweb12624474.htm
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ecopetrol files its 20-F Annual Report before the Securities and Exchange Commission
- Pioneering Nuclear Technology Firm, Curio, Closes $14 Million Seed Round to Drive Clean Energy Innovation
- UPDATE: LifeWallet Announces a Comprehensive Settlement with a Group of Affiliated Property & Casualty Insurers
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
iPhone 4Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!